FdaApplication
NDA 021654
Identifiers
- fda_app_no: NDA021654
Properties
| Property | Value |
|---|---|
| applicant_name | WAYLIS THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2004-11-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | CAPSULE;ORAL |
1 product